Fifty Percent Effective Dose of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children With Cyanotic and Acyanotic Congenital Heart Disease

被引:11
作者
Yang, Fei [1 ,2 ,3 ,4 ,5 ]
Li, Shangyingying [1 ,2 ,3 ,4 ,5 ]
Shi, Yuan [1 ,2 ,3 ,4 ,5 ]
Liu, Lu [1 ,2 ,3 ,4 ,5 ]
Ye, Mao [1 ,2 ,3 ,4 ,5 ]
Zhang, Jin [1 ,2 ,3 ,4 ,5 ]
Liu, Hui [1 ,2 ,3 ,4 ,5 ]
Liu, Feng [1 ,2 ,3 ,4 ,5 ]
Yu, Qing [1 ,2 ,3 ,4 ,5 ,6 ]
Sun, Mang [1 ,2 ,3 ,4 ,5 ,6 ]
Tian, Qin [1 ,2 ,3 ,4 ,5 ]
Tu, Shengfen [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Chongqing Med Univ, Dept Anesthesiol, Childrens Hosp, 136,Second Zhongshan Rd, Chongqing, Peoples R China
[2] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China
[3] Natl Clin Res Ctr Child Hlth & Disorders Chongqin, Chongqing, Peoples R China
[4] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China
[5] Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China
[6] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Pediat, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
dexmedetomidine; sedation; transthoracic echocardiography; CHLORAL HYDRATE SEDATION; PREMEDICATION; MIDAZOLAM; PHARMACOKINETICS; ANESTHESIA; RESPONSES; INFANTS; ROUTES;
D O I
10.1053/j.jvca.2019.11.037
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: To determine the 50% and 95% effective dose of intranasal dexmedetomidine sedation for transthoracic echocardiography in children with cyanotic and acyanotic congenital heart disease. Design: A prospective, nonrandomized study. Setting: A tertiary care teaching hospital. Participants: Patients younger than 18 months with known or suspected congenital heart disease scheduled for transthoracic echocardiography with sedation. Interventions: Patients were divided into a cyanotic group (blood oxygen saturation <85%) or an acyanotic group (blood oxygen saturation >= 85%). This study used Dixon's up-and-down method sequential allocation design. In both groups, the initial dose of intranasal dexmedetomi- dine was 2 mu g/kg and the gradient of increase or decrease was 0.25 mu g/kg. Measurements and Main Results: The 50% effective dose (95% confidence interval) of intranasal dexmedetomidine sedation for transthoracic echocardiography was 3.2 (2.78-3.55) mu g/kg and 1.9 (1.69-2.06) mu g/kg in the cyanotic and acyanotic groups, respectively. None of the patients experienced significant adverse events. Conclusion: The 50% (95% confidence intervals) effective doses of intranasal dexmedetomidine sedation for transthoracic echocardiography were 3.2 (2.78-3.55) mu g/kg and 1.9 (1.69-2.06) mu g/kg in children with cyanotic and acyanotic congenital heart disease, respectively. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:966 / 971
页数:6
相关论文
共 33 条
[1]   THE POSTANESTHESIA RECOVERY SCORE REVISITED [J].
ALDRETE, JA .
JOURNAL OF CLINICAL ANESTHESIA, 1995, 7 (01) :89-91
[2]  
[Anonymous], NELSON TXB PEDIAT
[3]   Vascular endothelial growth factor in children with cyanotic and acyanotic and congenital heart disease [J].
Baghdady, Yasser ;
Hussein, Yasser ;
Shehata, Mohamed .
ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (02) :221-225
[4]   Intranasal dexmedetomidine: an effective sedative agent for electroencephalogram and auditory brain response testing [J].
Baier, Nicole M. ;
Mendez, Suzanne S. ;
Kimm, Danielle ;
Velazquez, Amanda E. ;
Schroeder, Alan R. .
PEDIATRIC ANESTHESIA, 2016, 26 (03) :280-285
[5]   SERIAL MAGNETIC-RESONANCE-IMAGING IN NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY [J].
BYRNE, P ;
WELCH, R ;
JOHNSON, MA ;
DARRAH, J ;
PIPER, M .
JOURNAL OF PEDIATRICS, 1990, 117 (05) :694-700
[6]  
CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244
[7]  
Ercan S, 2009, ANATOL J CARDIOL, V9, P486
[8]  
Fett J, 2017, J PEDIATR INTENSIVE, V6, P182, DOI 10.1055/s-0036-1597696
[9]   PROGNOSTIC IMPORTANCE OF BRAIN-STEM AUDITORY EVOKED-RESPONSES AFTER ASPHYXIA [J].
HECOX, KE ;
CONE, B .
NEUROLOGY, 1981, 31 (11) :1429-1434
[10]   Bioavailability of dexmedetomidine after intranasal administration [J].
Iirola, Timo ;
Vilo, Sanna ;
Manner, Tuula ;
Aantaa, Riku ;
Lahtinen, Maria ;
Scheinin, Mika ;
Olkkola, Klaus T. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (08) :825-831